15 participants
A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-07-11
- Start Date:
- 2024-07-15
- Completion:
- 2025-07-15
Conditions
- CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome
- EBV
- Hemophagocytic Lymphohistiocytoses
Interventions
- OTHER
No Results Yet